AI-driven analysis of MRI scans could pave the way for improved multiple sclerosis treatment

New research exploring cutting-edge Artificial Intelligence (AI) technology to better analyse MRI scans of patients with multiple sclerosis (MS) could unlock crucial insights into disease progression and pave the way for improved treatment of people living with the condition.

Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical Officer | Psychedelic Invest

Delix Therapeutics, a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological conditions, today announced the appointment of Dr. Aaron Koenig as Chief Medical Officer. Dr.

June 12, 2023

Anti-estrogenic therapies can suppress growth of ER-negative cancers

Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression

August 21, 2023

In Brief: ICER Issues Final Evidence Report and Recommendations Re: MDMA-Assisted Therapy; Lykos Responds – Psychedelic Alpha

Aside from issuing its final report (which we don’t discuss in detail here owing to its similarity to that discussed in our earlier coverage, above),

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.